AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine neoplasia type 1.

Findings seen in women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer.

Given inadequate recognition of endocrine disorder in critical illness, the goal of this Research Topic is to promote recent advances in the field of abnormal endocrine metabolism in critical illness ...

tumors in the endocrine system. The approval covers patients 12 and older with locally advanced, unresectable or metastatic PPGL and makes Welireg the first oral treatment for advanced PPGL ...

Credit: AbbVie. The FDA approved the VENTANA MET (SP44) RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis ...

China cNational Clinical Research Center on Mental Disorders (Xiangya), Changsha, Hunan, China dNational Center for Mental Disorder, Changsha, Hunan, China ...

Novo lumps sales of Norditropin and Sogroya together into its rare endocrine disorders category, which grew sales 31% in 2024 to roughly 5 billion Danish kroner ($745 million). Analytics firm ...

Provider perspectives on barriers and facilitators to adjuvant endocrine therapy-related symptom management. This is an ASCO Meeting Abstract from the 2016 Cancer Survivorship Symposium. This abstract ...